![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 239/48 | (2006.01) |
C07D 405/12 | (2006.01) | ||
C07D 403/12 | (2006.01) | ||
C07D 401/12 | (2006.01) | ||
C07D 401/14 | (2006.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 35/00 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
C07D 405/14 | (2006.01) |
(11) | Number of the document | 2275413 |
(13) | Kind of document | T |
(96) | European patent application number | 10009414.3 |
Date of filing the European patent application | 2004-03-12 | |
(97) | Date of publication of the European application | 2011-01-19 |
(45) | Date of publication and mention of the grant of the patent | 2013-03-06 |
(46) | Date of publication of the claims translation | 2013-07-25 |
(30) | Number | Date | Country code |
0305929 | 2003-03-14 | GB | |
0319227 | 2003-08-15 | GB | |
0322370 | 2003-09-24 | GB |
(72) |
Garcia-Echeverria, Carlos, CH
Kanazawa, Takanori, JP
Kawahara, Eiji, JP
Masuya, Keiichi, CH
Matsuura, Naoko, JP
Miyake, Takahiro, JP
Ohmori, Osamu, JP
Umemura, Ichiro, JP
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 2,4-di(fenilamino)-pirimidinai, naudingi neoplastinių ligų, uždegiminių ir imuninės sistemos sutrikimų gydyme |
2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
Payment date | Validity (years) | Amount | |
2023-03-07 | 347.00 EUR |